Medically reviewed by Kelly Wood, MDMedically reviewed by Kelly Wood, MD Adrenal cancer occurs when a malignant (cancerous) ...

Merck MRK announced that the FDA has accepted its supplemental new drug application (sNDA) seeking approval of its oral ...

The FDA has accepted a priority review sNDA for Welireg in adults and pediatric patients with advanced or metastatic ...

We have a deep understanding of how to evaluate your condition and how select and combine treatments to get the best possible results — even for rare cancers that many doctors in the community never ...

Cancer Research UK, Cytovation, and the Norwegian Cancer Society collaborate to advance treatment for adrenocortical ...

Adrenal tumors, which can be benign or malignant, often require effective treatment options to manage symptoms and prevent complications. Ablation techniques have emerged as minimally invasive ...

The FDA granted priority review for belzutifan for treating advanced pheochromocytoma and paraganglioma, with a PDUFA date ...

Merck & Co. has won U.S. Food and Drug Administration priority review for its application seeking expanded use of its Welireg oral cancer drug in patients with rare tumors that form in and around the ...

The Department of Urology in AIIMS Bhopal successfully treated 13 hormonally active adrenal tumors in the past year using advanced laparoscopic techniques, demonstrating the institution's innovation ...

The combination of Opdivo and Yervoy is supported by updated results as a standard of care for MSI-H or dMMR metastatic ...

Cushing’s syndrome, or hypercortisolism, is a condition caused by overproduction of cortisol — a hormone that regulates stress, metabolism, and immune response. While cortisol ...